Has Chengyuan Wu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $377,026 in general payments to Chengyuan Wu, MD across 681 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chengyuan Wu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chengyuan Wu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chengyuan Wu, MD

Neurological Surgery · Philadelphia, PANPI 1811160823

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Medtronic at 42.4% of the total. Reporting peaked in 2023 at $84,302 and has fallen 66.3% since, to $28,434 in 2025. Among neurological surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$377,026in general payments, 2019–2025

Across 681 payments — averaging $553.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$160K
Nevro Corp.$69K
Abbott$53K
Biotronik Inc.$24K
Surgical Information Sciences, Inc.$22K
Boston Scientific$21K
plus $28K from 11 others

$235,846in research payments, 2019–2025

Across 62 payments — averaging $3803.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Nevro Corp.$165K
Abbott$51K
Medtronic$14K
Tyber Medical, LLC$6K

What the payments were for

Consulting fees$148,86839%
Speaking & faculty fees$169,97545%
Travel & lodging$35,7069%
Food & beverage$22,4766%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	198	$159,818
Nevro Corp.	188	$68,761
Abbott	164	$53,390
Biotronik Inc.	29	$23,742
Surgical Information Sciences, Inc.	1	$22,200
Boston Scientific	39	$20,831
Neuroone Medical Technologies Corporation	8	$16,088
Neuropace, Inc.	6	$3,663
Brainlab, Inc.	5	$3,000
Insightec,inc	12	$1,957
Globus Medical	21	$1,782
Actuated Medical, Inc.	1	$700
Renishaw Healthcare Inc.	1	$650
Zimmer Biomet	2	$235
MML US, Inc.	3	$114
Biotronik NRO, Inc.	1	$51
Chiesi USA, Inc.	2	$45

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VISUALASE$66,830
STEALTHSTATION S8 PLATFORM$29,827
Senza Spinal Cord Stimulation System$25,402
STEALTH AUTOGUIDE SYSTEM$24,454
Omnia$22,731
SIS System$22,200
Neuromodulation Dspsbls and Accs$21,134
Senza$18,227
INFINITY$18,213
PERCEPT PC BRAINSENSE$13,090
GENERAL DBS$12,864
Stealth Autoguide$10,881
Proclaim IPG$8,054
O-ARM$7,834
RNS System$3,290
Surgical planning and navigation radiation treatment planning and positioning$3,000
VERCISE$2,320
Exablate$1,694
Infinity DBS Pulse Generators$1,479
Neuromate Stereotactic Robot$650

How this compares

$377,026 in reported general payments places this provider in the 95th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$102,754

Medicare patients

169

Services billed

426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Philadelphia

Amer SamdaniPhiladelphia$4.4M
Brian JankowitzPhiladelphia$823K
Joshua HellerPhiladelphia$519K
Srinivas PrasadPhiladelphia$513K
John ShinPhiladelphia$306K
Omar ChoudhriPhiladelphia$304K
Pascal JabbourPhiladelphia$198K
Casey HalpernPhiladelphia$186K
Steven FulopPhiladelphia$140K
Kyle MuellerPhiladelphia$138K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →